Coronado Research Welcomes Jo Marshall as New EVP for Data Services and Advanced Analytics

Coronado Research Welcomes Jo Marshall as EVP of Data Services and Advanced Analytics



Coronado Research has exciting news for the pharmaceutical and biotechnology sectors. The firm recently announced the appointment of Jo Marshall as the new Executive Vice President (EVP) of Data Services and Advanced Analytics. With a strong background in clinical development, Jo joins the team to spearhead efforts in utilizing data-driven techniques that drive effective drug development processes.

Jo Marshall's expertise spans across various dimensions of clinical development, having spent much of her career focused on resolving complex challenges related to technology and data management. Her role will involve optimizing drug development programs, ensuring patient safety and data reliability remain at the forefront of decisions made within the organization.

Andrew MacGarvey, CEO of Coronado Research, expressed his enthusiasm, stating, "Jo brings a wealth of experience to the team. She is an industry leader who embraces the need for evolution and adaptation in processes and technology. Her strategic direction coupled with operational expertise will help us integrate the comprehensive data necessary for successful development programs."

As someone who leads with innovation in mind, Jo is set to drive transformative change at Coronado Research. She aims to enhance the integration of clinical development with market access, paving the way for groundbreaking advancements within the industry. Jo highlighted her passion for improving patient outcomes by stating, "When Andrew explained his mission for Coronado Research, I realized that I could contribute significantly to this vision. I've witnessed firsthand the barriers that therapies in rare diseases face and the difficulties of balancing patient prioritization against development costs. I look forward to bridging this gap and enabling our industry to adapt to shifting therapeutic landscapes."

About Coronado Research


Coronado Research is a consultancy-led, professional services organization dedicated to supporting pharmaceutical, biotechnology, and medical device companies. The firm’s mission revolves around optimizing the clinical development process by employing advanced technologies, including artificial intelligence (AI) and machine learning (ML). The comprehensive service provided by Coronado Research encompasses several key areas:

  • - Regulatory Strategy: Ensuring compliance with governmental regulations.
  • - Advanced Analytics: Using transformative analytics tools to maximize data usage.
  • - Market Access and Health Economics: Bridging the gap between clinical effectiveness and market viability.
  • - Technology Integration: Merging technological advancements with clinical strategies.

With Jo's appointment, Coronado Research aims to encapsulate the golden thread of data essential for developing treatments that align with market needs. By focusing its efforts on collaborative integration, the organization seeks to foster innovation while enhancing patient safety throughout the drug development continuum.

This strategic hire underscores the company's commitment to bringing experienced professionals into pivotal roles that further its mission of optimizing healthcare outcomes using sophisticated data strategies. Jo’s vision not only reinforces Coronado Research’s standing in the competitive biotech consulting field but also acknowledges the industry's needs for expertise in tackling today's complex challenges in clinical trials and their subsequent market applications.

Coronado Research looks forward to the advancements Jo Marshall will instigate within their team, as they continue to fulfill their promise to deliver superior service and innovative solutions to their clientele.

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.